andre megarbane

Prof. Dr. andre megarbane

orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2009 in Genetics in Medicine
Verified
Journal Article
Closed access
AMandre megarbane
andre megarbane
ARAimé Ravel
Aimé Ravel
CMClotilde Mircher
Clotilde Mircher
Franck SturtzFranck Sturtz
Franck Sturtz
YGYann Grattau
Yann Grattau
WMWilliam C. Mobley
William C. Mobley

1 October 2007 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
LALynn Adaimy
Lynn Adaimy
ECEliane Chouery
Eliane Chouery
HMHala Mégarbané
Hala Mégarbané
SMSalman Mroueh
Salman Mroueh
VDValérie Delague
Valérie Delague
AMandre megarbane
andre megarbane

17 June 2005 in Journal of Medical Genetics
Verified
Journal Article
Open access
PDF file
LML Van Maldergem
L Van Maldergem
HSH A Siitonen
H A Siitonen
NJN Jalkh
N Jalkh
ECEliane Chouery
Eliane Chouery
MRM De Roy
M De Roy
AVA Verloes
A Verloes
Baller-Gerold syndrome (BGS) is a rare autosomal recessive condition with radial aplasia/hypoplasia and craniosynostosis (OMIM 218600). Of >20 cases reported so far, a few appear atypical and have been reassigned to other nosologic entities, including Fanconi anaemia, Roberts SC phocomelia, and Pfeiffer syndromes after demonstration of corresponding cytogenetic or molecular abnormalities. Clinical overlap between BGS, Rothmund-Thomson syndrome (RTS), and RAPADILINO syndrome is noticeable. Because patients with RAPADILINO syndrome and a subset of patients with RTS have RECQL4 mutations, we reassessed two previously reported BGS families and found causal mutations in RECQL4 in both. In the first family, four affected offspring had craniosynostosis and radial defect and one of them developed poikiloderma. In this family, compound heterozygosity for a R1021W missense mutation and a g.2886delT frameshift mutation of exon 9 was found. In the second family, the affected male had craniosynostosis, radial ray defect, poikiloderma, and short stature. He had a homozygous splice site mutation (IVS17-2A>C). In both families, the affected offspring had craniosynostosis, radial defects, and growth retardation, and two developed poikiloderma. Our results confirm that BGS in a subgroup of patients is due to RECQL4 mutations and could be integrated into a clinical spectrum that encompasses RTS and RAPADILINO syndrome.

10 June 2008 in Human Mutation
Verified
Journal Article
Open access
PDF file
ECEliane Chouery
Eliane Chouery
VDValérie Delague
Valérie Delague
ABAnne Bergougnoux
Anne Bergougnoux
SKSalam Koussa
Salam Koussa
JSJean-Louis Serre
Jean-Louis Serre
AMandre megarbane
andre megarbane
A genome-wide screen using 382 STR markers to localize and identify the gene implicated in early-onset dementia (EOD) without bone cysts in a Lebanese family with three affected subjects was conducted. A unique locus homozygous by descent at chromosome 6p21.2 locus was identified. Candidate genes were explored by fluorescent sequencing and the effect of the identified mutation was confirmed by qualitative and quantitative RT-PCR. The genetic analysis revealed a novel deletion, c.40+3delAGG, in the 5' consensus donor splice site in intron 1 of TREM2 gene which is known to be responsible for PLOSL (Polycystic Lipomembranous Osteodysplasia with Sclerosing Leukoencephalopathy) also designated as Nasu-Hakola disease. In silico analysis predicted a lower strength for the novel donor splice site. Qualitative RT-PCR revealed normal transcript while quantitative RT-PCR showed over twofold down-regulation of TREM2 transcripts. The expression profile of six genes SPP1, NEDD9, FSCN, BCL3, NFKBIA and CCL2 known as disrupted in TREM2-deficient samples was studied and showed same expression profile as TREM2-mutated samples except for CCL2 which was normally regulated. The significantly-reduced expression of TREM2 in our patients and the expression profiles of the six studied genes confirm a role for TREM2 in this distinct phenotype of EOD without bone cysts. To our knowledge, this is the first report of mutations in TREM2 causing a pure dementia.

1 July 2000 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
VDValérie Delague
Valérie Delague
CBCorinne Bareil
Corinne Bareil
STSylvie Tuffery
Sylvie Tuffery
PBPatrice Bouvagnet
Patrice Bouvagnet
ECEliane Chouery
Eliane Chouery
MCMireille Claustres
Mireille Claustres

1 January 2013 in European Journal of Endocrinology
Verified
Journal Article
Open access
PDF file
MGMarie-Hélène Gannagé-Yared
Marie-Hélène Gannagé-Yared
JKJürgen Klammt
Jürgen Klammt
ECEliane Chouery
Eliane Chouery
SCSandra Corbani
Sandra Corbani
HMHala Mégarbané
Hala Mégarbané
AMandre megarbane
andre megarbane
Background: Heterozygous mutations in the IGF1 receptor (IGF1R) gene lead to partial resistance to IGF1 and contribute to intrauterine growth retardation (IUGR) with postnatal growth failure. To date, homozygous mutations of this receptor have not been described.Subject: A 13.5-year-old girl born from healthy first-cousin parents presented with severe IUGR and persistent short stature. Mild intellectual impairment, dysmorphic features, acanthosis nigricans, and cardiac malformations were also present.Methods: Auxological and endocrinological profiles were measured. All coding regions of theIGF1Rgene including intron boundaries were amplified and directly sequenced. Functional characterization was performed by immunoblotting using patient's fibroblasts.Results: IGF1 level was elevated at 950 ng/ml (+7s.d.). Fasting glucose level was normal associated with high insulin levels at baseline and during an oral glucose tolerance test. Fasting triglyceride levels were elevated. Sequencing of theIGF1Rgene led to the identification of a homozygous variation in exon 2: c.119G>T (p.Arg10Leu). As a consequence, IGF1-dependent receptor autophosphorylation and downstream signaling were reduced in patient's fibroblasts. Both parents were heterozygous for the mutation.Conclusion: The homozygous mutation of theIGF1Ris associated with severe IUGR, dysmorphic features, and insulin resistance, while both parents were asymptomatic heterozygous carriers of the same mutation.